(Q58614979)

English

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eduardo Díaz-Rubio

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Josep Tabernero Caturla

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

E Aranda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Cervantes

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Antón-Torres

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Carrato

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

T Massutí

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Sastre

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Trés

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J Aparicio

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J M López-Vega

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

I Barneto

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J García-Conde

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 July 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

727-731

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Editorial: Large-bowel cancer-The current status of treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of chemotherapy in the treatment of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous Infusion or Bolus Injection in Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Intention-to-treat analysis and the goals of clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008282824860

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008282824860

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9739438%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58614979&oldid=1584669402"